Lead sponsor
Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
1
Trials led
1
Active
938
Total enrollment
1
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Trials by status
Not yet recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshHbA1c 7-10%Ph 4Not yet recruiting938